u/burned_once_twice

Name removed. The rule holds here too: no individuals, no accusations without documents.

Name removed. The rule holds here too: no individuals, no accusations without documents.

Stopped at a low step because there was no reason to go further and no data to tell me what further would do.

Not convinced that was avoidable. Some of this is genuinely bad luck and treating everything as a lesson is its own trap.

Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.

Agreed on potency testing of the finished preparation. That is a different question from the purity of the starting material.

Left up, flaired Correction. The original stays with it — that is how this board works.

Left up, flaired Correction. The original stays with it — that is how this board works.

a log with no dates is a story

do not assume the concentration matches the branded product

Was there a point where the information was available and you did not look?

What is the beyond-use date and what is it based on?

shortage status changes and the whole arrangement changes with it

salt forms are the recurring argument and the answer is boring

the phase 2 numbers were striking and they were also 48 weeks in a small population

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

Sent a vial to VendorInvestigate out of curiosity. Result was 97.4% against a claimed 97.0%, which is the first independent number I had seen for this compound anywhere.

Name removed. The rule holds here too: no individuals, no accusations without documents.

if a clinic will not name the facility, that is your answer

ask which facility, then ask for their testing

Adding one thing — ask for the facility name. Most will give it, and the ones that will not have answered you.

baseline before you start is worth more than any later panel

a lot of the confident posting here is extrapolation

the fridge failure story happens every summer

Sent a vial to Medutest out of curiosity. Result was 98.1% against a claimed 97.5%, which is the first independent number I had seen for this compound anywhere.

Accused the wrong party publicly and it was my storage. Correcting it here was the most uncomfortable post I have made and the right one.

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

Push back: a value just outside a reference interval is a common finding in healthy people.

Disagreeing with this bit: that change is confounded by the weight loss itself and cannot be attributed.

The confounding problem, stated plainly, because this board keeps stepping on it.

This is the sentence to read before anybody panics about a single value.

Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.

That figure is the starting material purity, not the finished preparation potency. Two different tests.

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

assay method matters, especially between different labs

The attribution problem, which is the reason most logs on this board cannot answer the question their owner is asking.

If dose, training, intake and sleep all changed in the same fortnight, no analysis of the resulting numbers can tell you which one moved the outcome. That is not a limitation of your spreadsheet; it is a limitation of the design.

The fix is unglamorous: change one thing at a time, leave it long enough to see, and annotate the weeks where something else intruded anyway — because life will intrude. A log with honest annotations answers questions. A log with four simultaneous changes and a confident conclusion is the most common thing posted here, and it does not.

Read the phase 2 paper twice before ordering anything.

This is the sentence the rest of the board should read first. Phase 2 is not a label.

Contemporaneous or reconstructed?

What is the one column you added late and wish you had from the start?

Did anything else change in the window you are asking about?

research-use-only material is not approved for human use, full stop

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

What did the repeat show?